Modelling estimates suggest that new HIV infections in the US could be reduced by as much as 94% before 2030, if the current HIV prevention budget is spent more efficiently. Priorities would be linking those diagnosed with HIV to care, ensuring that they receive treatment and getting them to the point of viral suppression. Less… Read More »
In the video above, Dr. Andrew Saul, editor-in-chief of the Orthomolecular Medicine News Service, presents valuable information on the importance of vitamin C for disease treatment, including COVID-19 — information that’s being widely silenced via organized censorship.1 His Tokyo presentation, “Orthomolecular Medicine and Coronavirus Disease: Historical Basis for Nutritional Treatment,” highlights the fact that when… Read More »
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »
Print this page London UK 9 September 2020 — GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to… Read More »
Treatment for Diabetic Foot Ulcers Treatment for Diabetic Foot Ulcers : An ulcer or a wound is a break in the skin. It is open sore and this condition effects about 20% of diabetic patients. Diabetic foot ulcers are commonly located at the bottom of the foot. The main reason people with diabetes develop foot ulcers… Read More »
FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy Print this page PARAMUS, N.J., Aug. 12, 2020 /PRNewswire/ — NS Pharma, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved Viltepso (viltolarsen) injection for patients with Duchenne muscular dystrophy (DMD) who… Read More »